Search

In conversation with Derrick DeSilva

We were delighted to chat to Dr Derrick DeSilva, internationally recognised expert in optimal ageing and longevity medicine, about his career and involvement in next year’s AMWC Monaco. Derrick DeSilva. What first attracted you to medicine and what then led...

In conversation with Emanuele Bartoletti (2024)

We were delighted to catch up with Dr Emanuele Bartoletti, President of Società Italiana di Medicina Estetica (SIME), about the latest news from the society. You have been involved with SIME for many years now; what have been the highlights...

In conversation with Fateh Ahmad

We spoke to Fateh Ahmad about his career in plastic & craniofacial surgery, advice to those new to the field and his new role as President of the RSM Section of Plastic Surgery Can you tell us a little bit...

Can 3D facial imaging improve patient management in disfiguring eye disease?

Fight for Sight is the leading UK charity funder of eye research. Since the 2013 Sight Loss and Vision Priority Setting Partnership we have encouraged our researchers to work on priorities jointly identified by people affected by sight loss and...

Burns care in India: unique and continuing challenges

The author interviews Dr Shobha Chamania, Chief of Choithram Hospital Burn Unit, to obtain an insight into the unique challenges burns care practitioners face in India. Choithram Hospital Burn Unit is an Interburns accredited training centre located in Indore City,...

Botulinum toxin (BoNT) for depression: A review of the mechanism of action and its potential place as an adjuvant treatment

BoNT is becoming a recognised efficient treatment for depression, endorsed by several disciplines including psychiatry. Clare Amrani examines the potential mechanism of action and explores the appropriate place of BoNT in the therapeutic armamentarium for depression. How did BoNT become...

Extracutaneous Merkel cell carcinoma or metastatic Merkel cell carcinoma with an occult primary?

Merkel cell carcinoma (MCC) is a rare and aggressive malignancy arising from dermal neuroendocrine cells, first described by Toker in 1972 [1]. It is predominately seen in the head and neck region of older, white males and risk factors include...

A novel integrated practice unit (IPU) approach to periocular skin cancer management

The COVID-19 pandemic was one of the biggest challenges to face NHS workers. However, history has repeatedly shown that times of difficulty can result in the development of significant social and technological advances. We describe our own experience of this...

A guide to hair transplantation

A leading hair transplant surgeon provides an overview of the most effective surgical treatments for hair restoration – and how the industry will develop over the next decade. Modern hair transplant techniques were first developed in Japan in the 1930s...